| Symbols and Abbreviations |
|
ix | |
|
Section I Introduction to heart failure |
|
|
|
1 Definition of heart failure, basic epidemiology, and pathophysiology |
|
|
3 | (16) |
|
Section II Chronic heart failure |
|
|
|
2 Diagnosis and investigation |
|
|
19 | (12) |
|
|
|
31 | (12) |
|
4 Non-pharmacological management |
|
|
43 | (8) |
|
5 Pharmacological management |
|
|
51 | (12) |
|
6 Device therapy: which devices and for whom? |
|
|
63 | (22) |
|
7 Coronary revascularization in heart failure |
|
|
85 | (6) |
|
8 Other surgical techniques |
|
|
91 | (8) |
|
9 Cardiac transplantation |
|
|
99 | (16) |
|
10 Mechanical circulatory support |
|
|
115 | (18) |
|
Section III Heart failure and co-morbidities |
|
|
|
11 CHF and adult congenital heart disease |
|
|
133 | (14) |
|
12 The patient with CHF and anaemia |
|
|
147 | (6) |
|
13 The patient with CHF and angina |
|
|
153 | (6) |
|
14 The patient with CHF and arrhythmias |
|
|
159 | (12) |
|
15 The patient with CHF and arthritis |
|
|
171 | (10) |
|
16 The patient with CHF and cancer |
|
|
181 | (12) |
|
17 The patient with CHF and diabetes |
|
|
193 | (6) |
|
18 The patient with CHF and obstructive lung disease |
|
|
199 | (4) |
|
19 The pregnant patient with HF |
|
|
203 | (12) |
|
20 The patient with CHF and preserved LV systolic function (HF-PEF) |
|
|
215 | (10) |
|
21 The patient with CHF and renal dysfunction |
|
|
225 | (8) |
|
22 The patient with CHF and RV dysfunction |
|
|
233 | (4) |
|
23 The patient with CHF and specific heart muscle disease |
|
|
237 | (48) |
|
24 The patient with CHF and valvular heart disease |
|
|
285 | (20) |
|
Section IV Acute heart failure |
|
|
|
25 Acute heart failure: from definition to diagnosis |
|
|
305 | (12) |
|
26 Acute heart failure: management |
|
|
317 | (20) |
|
|
|
|
27 Central venous cannulation |
|
|
337 | (4) |
|
28 Cardiac catheterization |
|
|
341 | (14) |
|
|
|
355 | (6) |
|
|
|
361 | (6) |
|
31 Cardio-pulmonary exercise testing |
|
|
367 | (4) |
|
|
|
371 | (6) |
|
Section VI Detailed pharmacology and evidence base for drugs |
|
|
|
|
|
377 | (8) |
|
34 β-adrenoreceptor antagonists |
|
|
385 | (10) |
|
35 Mineralocorticoid receptor antagonists (MRAs) |
|
|
395 | (8) |
|
36 Angiotensin receptor antagonists |
|
|
403 | (10) |
|
37 Diuretics and aquaretics |
|
|
413 | (10) |
|
|
|
423 | (8) |
|
39 Inotropes and vasopressors |
|
|
431 | (14) |
|
|
|
445 | (12) |
|
Section VII Multi-professional heart failure care |
|
|
|
41 Heart failure services |
|
|
457 | (10) |
|
|
|
467 | (10) |
| Index |
|
477 | |